1-2 of 2
Keywords: response
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Baseline monocyte and its classical subtype may predict efficacy of PD-1/PD-L1 inhibitor in cancers

Yilin Shao, Shuchen Lin, Ping Zhang, Jian Zhang, Dongmei Ji, Zhonghua Tao, Xichun Hu
Journal: Bioscience Reports
Biosci Rep (2021) 41 (1): BSR20202613.
DOI: https://doi.org/10.1042/BSR20202613
Published: 29 January 2021
...Yilin Shao; Shuchen Lin; Ping Zhang; Jian Zhang; Dongmei Ji; Zhonghua Tao; Xichun Hu Background: Programmed death 1 (PD-1)/ programmed death-ligand 1 (PD-L1) inhibitor is one of the most popular immune therapies. Biomarkers for predicting response are highly needed, but no biomarkers are widely...
View article
PDF
Includes: Supplementary data
Articles

Association of UGT1A1*6 polymorphism with irinotecan-based chemotherapy reaction in colorectal cancer patients: a systematic review and a meta-analysis

Xiaoyun Zhu, Ruchao Ma, Xin Ma, Gang Yang
Journal: Bioscience Reports
Biosci Rep (2020) 40 (10): BSR20200576.
DOI: https://doi.org/10.1042/BSR20200576
Published: 21 October 2020
... a central role in the IRI metabolic pathway. A polymorphism UGT1A1*6 has been widely researched which may be related to response of IRI-based chemotherapy in CRC. All relevant studies were strictly searched from PubMed, Embase, Cochrane Library and Web of Science databases to explore the associations...
View article
PDF